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Abstract. 
 
Laminin-5 (Ln-5) is an extracellular matrix 
substrate for cell adhesion and migration, which is 
found in many epithelial basement membranes. Mecha-
nisms eliciting migration on Ln-5 need to be elucidated 
because of their relevance to tissue remodeling and 
cancer metastasis. We showed that exogenous addition 
of activated matrix metalloprotease (MMP) 2 stimu-
lates migration onto Ln-5 in breast epithelial cells via 
cleavage of the 
 
g
 
2 subunit. To investigate the biological 
scope of this proteolytic mechanism, we tested a panel 
of cells, including colon and breast carcinomas, hepato-
mas, and immortalized hepatocytes, selected because 
they migrated or scattered constitutively in the pres-
ence of Ln-5. We found that constitutive migration was 
inhibited by BB94 or TIMPs, known inhibitors of 
MMPs. Limited proﬁling by gelatin zymography and 
Western blotting indicated that the ability to constitu-
tively migrate on Ln-5 correlated with expression of 
plasma membrane bound MT1-MMP metalloprotease, 
rather than secretion of MMP2, since MMP2 was not 
produced by three cell lines (one breast and two colon 
carcinomas) that constitutively migrated on Ln-5. 
Moreover, migration on Ln-5 was reduced by MT1-
MMP antisense oligonucleotides both in MMP2
 
1
 
 and 
MMP2
 
2
 
 cell lines. MT1-MMP directly cleaved Ln-5, 
with a pattern similar to that of MMP2. The he-
mopexin-like domain of MMP2, which interferes
with MMP2 activation, reduced Ln-5 migration in 
MT1-MMP
 
1
 
, MMP2
 
1
 
 cells, but not in MT1-MMP
 
1
 
, 
MMP2
 
2
 
 cells. These results suggest a model whereby 
expression of MT1-MMP is the primary trigger for mi-
gration over Ln-5, whereas MMP2, which is activated 
by MT1-MMP, may play an ancillary role, perhaps by 
amplifying the MT1-MMP effects. Codistribution of 
MT1-MMP with Ln-5 in colon and breast cancer tissue 
specimens suggested a role for this mechanism in inva-
sion. Thus, Ln-5 cleavage by MMPs may be a wide-
spread mechanism that triggers migration in cells con-
tacting epithelial basement membranes.
Key words: migration • extracellular matrix • epithe-
lial cell • invasion
 
Introduction
 
Cell motility is a determinant of epithelial morphogenesis
and regeneration (Thiery, 1984). An important issue is to
define the molecular nature of spatial cues in the environ-
ment surrounding epithelial cells, which may signal initia-
tion of migration during processes such as tissue remodel-
ing or wound healing. Finding and characterizing these
cues should make it possible to understand and manipu-
late epithelial tissue organization and pathological condi-
tions such as metastasis.
The extracellular matrix (ECM)
 
1
 
 of the basement mem-
branes (BMs) is a likely structural site for motility cues
since the BM is a critical interface between epithelial cells
and the rest of the body. Laminin-5 (Ln-5), an ECM glyco-
protein found in the BM, is a strong candidate for playing
a major role in epithelial cell motility (Miyazaki et al.,
1993b; Giannelli et al., 1997). We hypothesized that it may
act not only as a passive ECM substrate (Roskelley et al.,
1995; Malinda and Kleinman, 1996), but may actively par-
ticipate in the regulatory aspects of motility.
Ln-5 is a recognized ligand for integrins 
 
a
 
6
 
b
 
4 and 
 
a
 
3
 
b
 
1
(Carter et al., 1990; Jones et al., 1991; Niessen et al., 1994;
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Ryan et al., 1994). The interaction of Ln-5 with 
 
a
 
6
 
b
 
4 leads
to the assembly of hemidesmosomes, which are static ad-
hesive devices that anchor epithelial cells to the underly-
ing BM (Baker et al., 1996). Interestingly, though, Ln-5
was also shown to promote vigorous cell scattering when
added to the medium of epithelial cell cultures (Miyazaki
et al., 1993b; Giannelli et al., 1997). These apparently op-
posing functions of Ln-5 (i.e., the ability to induce either
static adhesion via hemidesmosomes [Jones et al., 1991] or
cell motility [Miyazaki et al., 1993b; Giannelli et al., 1997])
may reflect physiological mechanisms to maintain tissue
integrity: in quiescent tissues, Ln-5 may be predominantly
a static adhesive substrate, whereas during regenerative or
wound healing responses, it may deliver migratory stimuli.
In support of this hypothesis, primary breast epithelial cell
cultures, and the immortalized breast cell line MCF-10A,
become migratory on Ln-5 upon addition of activated
MMP2, an ECM metalloprotease (Giannelli et al., 1997).
An indication that this mechanism may have physiological
significance is that Ln-5 
 
g
 
2 fragments, corresponding in
size to those generated by MMP2 cleavage, are detectable
in remodeling, but not in quiescent mammary glands (Gi-
annelli et al., 1999) and in epithelial tumor tissue speci-
mens. Thus, MMP2 cleavage of Ln-5 may play a mechanis-
tic role in epithelial cell invasion during tissue remodeling
as well as in cancer invasion and metastasis. However,
these processes require some degree of spatial definition.
Since MMP2 is secreted in the extracellular space and it is
soluble, it is not clear how Ln-5 cleavage by MMP2 may be
spatially directed to discrete BM sites.
Several MMPs have been associated with the remodel-
ing of epithelial tissues as well as metastasis (Birkedal-
Hansen, 1995), but the molecular mechanisms remain
poorly understood (Werb et al., 1996). One critical issue is
MMP activation and its spatial restrictions. In the breast
epithelial cells we studied (primary cultures and MCF-
10A), exogenous addition of chemically activated MMP2
was an absolute requirement for Ln-5 cleavage and conse-
quent migration, raising the possibility of alternative,
though not mutually exclusive, scenarios including the fol-
lowing: (1) epithelial cells may rely on another cell, e.g.,
mesenchymal or inflammatory, to activate pro-MMP2,
cleave Ln-5, and migrate; (2) in cell cultures, MMP2 mim-
ics the activity of other physiological proteases, which may
be secreted and/or activated by epithelial cells; and (3) ep-
ithelial cells, upon responding to appropriate stimuli, may
secrete MMP2, express the MMP2 activation apparatus,
and thereby regulate migration on Ln-5 in an autonomous
fashion.
To investigate these possibilities, we characterized the
role of MMP during Ln-5 migration in a panel of cell lines
of distinct histologic derivation. These cell lines present
one critical difference with respect to MCF-10A and pri-
mary mammary epithelial cells: they do not require exoge-
nous addition and/or activation of MMPs, but rather they
migrate on Ln-5 constitutively. Here, we show that this
constitutive Ln-5 migration depends upon expression of
surface membrane type 1 (MT1)–MMP, which can both
directly cleave Ln-5 and activate MMP2, if present, for
further cleavage and migration. These data indicate that
the MMP cleavage mechanism for induction of migration
over Ln-5 may be of general importance in epithelial cells
contacting the BM. Furthermore, because MT1-MMP is
cell surface anchored, they provide a mechanism for
spatially defined formation of promigratory cues along
the BM.
 
Materials and Methods
 
Cell Lines and Culture Conditions
 
BRL is a nontumorigenic liver epithelial cell line from Buffalo rat (Nissley
et al., 1977). MCF-10A is a spontaneously immortalized human mammary
epithelium cell line, and 804G is a rat bladder carcinoma. Types of human
cancer cell lines are as follows: MDA-MB-231, breast carcinoma; DLD-1
and HT-29, colon carcinoma; HLE and HLF, hepatoma; and HT-1080, fi-
brosarcoma. BRL, MCF-10A, MDA-MB-231, DLD-1, HT29, and HT-
1080 cell lines were obtained from American Type Culture Collection.
HLE and HLF were obtained from the Japanese Cancer Resources Bank.
The 804G cell line was described previously (Falk-Marzillier et al., 1998).
Each cell line, except for MCF-10A, was maintained in DME (GIBCO
BRL) plus 10% (vol/vol) FCS (Irvine Scientific), penicillin, and strepto-
mycin. MCF-10A was maintained in DFC-1 plus 1% (vol/vol) FCS as de-
scribed previously (Plopper et al., 1998).
 
Purification of Rat Ln-5 from 804G Serum-free 
Conditioned Medium (CM)
 
Serum-free DME CM of 804G cells was prepared in roller bottles, concen-
trated 
 
z
 
100-fold by ammonium sulfate at 80% saturation and dialyzed
against 20 mM Tris-HCl (pH 7.5)/0.5M NaCl/0.005% Brij-35 (TNB
buffer). Nonfunctional Ln-5 mouse mAb TR-1 (Plopper et al., 1996) was
chemically conjugated to protein A–Sepharose 4B as previously reported
(Koshikawa et al., 1992). Concentrated CM was passed over the TR-1 an-
tibody column (0.8 
 
3
 
 4.0 cm; Bio-Rad Laboratories), previously equili-
brated with TNB buffer at a flow rate of 15 ml/h. After washing with TNB,
absorbed Ln-5 was eluted with 10 ml of 0.05% trifluoroacetic acid (TFA),
pH 2.5. Each eluted fraction (1 ml) was quickly neutralized by 300 
 
m
 
l of
1 M Tris-HCl, pH 8.0, and then 1% of CHAPS (wt/vol) was added to each
fraction.
 
Gelatin Zymography and Immunoblotting
 
Gelatin zymography was performed as reported (Koshikawa et al., 1992).
Serum-free CM was prepared from confluent cultures of each cell line in-
cubated for 48 h in serum-free basal media. The CMs were concentrated
 
z
 
30-fold by ammonium sulfate at 80% saturation and dialyzed against
TNB buffer (Koshikawa et al., 1992). Crude plasma membranes were pre-
pared from confluent cultures of each cell line incubated for 48 h in se-
rum-free basal medium. Cells were scraped in 0.25 M sucrose/10 mM
Hepes, pH.7.5, and then collected in Eppendorf tubes. The cell suspension
was homogenized at 4
 
8
 
C, nuclei removed by centrifugation at 3,000 rpm
for 5 min, the supernatant was centrifuged at 15,000 rpm for 30 min, and
the crude plasma membrane fraction was recovered as pellets. Immuno-
blotting was performed with rabbit polyclonal antibodies against human
membrane type 1 MMP (MT1-MMP) and mouse mAb against human tis-
sue inhibitor of metalloprotease-2 (TIMP-2) by reported methods
(Miyazaki et al., 1993a), except that the antigen was detected by the en-
hanced chemiluminescence method with a NEN Life Science Products kit.
 
Preparation of MMP2 and MMP Inhibitors
 
Human TIMP-2–free MMP2 was purified from serum-free CM of human
glioblastoma T98G cells (Miyazaki et al., 1993a). TIMP-1 and TIMP-2
were purified from serum-free CM of human bladder carcinoma EJ-1 cells
(Miyazaki et al., 1993a). Hemopexin-like domain (HLD) of MMP2 was
purified from human TIMP-2–free MMP2 treated with neutrophil
elastase, by Reactive-Red agarose affinity chromatography as described
before (Strongin et al., 1993; Rice and Banda, 1995). BB94 (Batimastat)
was a gift from British Biotechnology Ltd.
 
Bacterial Expression and Purification of Recombinant 
Rat MT1-MMP
 
Rat smooth muscle cell–derived MT1-MMP cDNA encoding amino acids
Ile
 
114
 
-Glu
 
528
 
 was amplified by a PCR using 5
 
9
 
- and 3
 
9
 
-primers with addi- 
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tional NdeI and EcoRI sites at the ends, respectively. The PCR products
were digested with these enzymes and subcloned into the pET-30a vector
(Novagen, Inc.), modified to express the FLAG peptide (Kinoshita et al.,
1998) fused to the COOH terminus of rat MT1-MMP protein in 
 
Escheri-
chia coli.
 
 Other experimental methods were performed as previously re-
ported (Kinoshita et al., 1998).
 
Cleavage of Ln-5 by MMP2 or MT1-MMP
 
5 
 
m
 
g of purified Ln-5 was incubated with 3.2 
 
m
 
g/ml of p-aminophenyl
mercuric acetate–activated MMP2 for 2 h at 37
 
8
 
C in 50 mM Tris, pH 7.5,
0.005% Brij-35, 10 mM CaCl
 
2
 
. In some cases, purified Ln-5 (1 
 
m
 
g) was ad-
sorbed onto a 96-well plate well, and then incubated with recombinant
MT1-MMP (0.2–2 
 
m
 
g/ml) for 16 h at 37
 
8
 
C in 50 mM Tris, pH 7.5, 0.005%
Brij-35, 10 mM CaCl
 
2
 
. After incubation, each reaction mixture was elec-
trophoresed on 6% SDS-PAGE under reducing conditions, and then ana-
lyzed by Western blotting with a rabbit polyclonal antibody against rat
Ln-5 
 
g
 
2 chain antibody (1963).
 
Cell Scattering Assay
 
BRL cells were placed into 24-well plates containing 0.5 ml of DME plus
1% FCS at 7,000 cells per well. Purified Ln-5 (80 ng/ml) was added. After
6–24 h, cells were fixed in 100% methanol for 10 min and stained with
0.5% crystal violet/20% methanol. Scattering was judged by microscopic
observation.
 
Cell Migration Assay
 
Cell migration assays were performed in Transwell chambers as reported
(Mizushima et al., 1997). Cells were resuspended in DME plus 0.1% (wt/
vol) BSA and seeded at 20,000 cells/well for BRL, MDA-MB-231, DLD-1,
and HT-29; 10,000 cells for HLF; and 5,000 cells for HLE. Ln-5 was added
to the lower chamber at 400 ng/ml (cancer cells) or 200 ng/ml (BRL). In
some cases, MMP2-cleaved, MMP inhibitors, antibodies, HLD of MMP2,
or oligonucleotides were also added, at indicated concentrations. After in-
cubation (16 h for BRL, DLD-1, and HT-29; 6 h for MDA-MB-231 and
HLE; 3.5 h for HLF), cells that migrated onto the lower surface of the fil-
ters were stained with 0.5% crystal violet/20% methanol and counted (Gi-
annelli et al., 1997).
 
Antisense Oligonucleotides
 
Rat and human MT1-MMP antisense (AS) oligonucleotide sequences and
their scrambled control oligonucleotides were designed by a computer
program (Advanced Gene Computing Technologies). The following phos-
phorothioate oligodeoxyribonucleotides were synthesized: AS oligonucle-
otide, 5
 
9
 
-TCGTGTCCGAATCGG-3
 
9
 
; control oligonucleotide, 5
 
9
 
-TCC-
GAGTTCTCGAGG-3
 
9
 
 for rat MT1-MMP, or AS oligonucleotide, 5
 
9
 
-
GCCGTAAAACTTCTG-3
 
9
 
; and control oligonucleotide, 5
 
9
 
-ATCTCG-
GATCAGACT-3
 
9
 
 for human MT1-MMP. These oligonucleotides were
freshly dissolved in PBS and added to BRL or HT-29 cells, respectively, at
10 
 
m
 
M. After 2 d of pretreatment with test or control oligonucleotides,
cells were tested in migration assays. Oligonucleotides were added to the
lower chamber of Transwells at 10 
 
m
 
M.
 
Confocal Microscopy
 
Double immunofluorescence and confocal microscopic analyses were per-
formed on 8-mm cryostat sections of human colon and breast carcinomas
(The Cooperative Tissue Network), fixed in freshly made 4% formalde-
hyde (from paraformaldehyde) for 20 min at 4
 
8
 
C, permeabilized in 0.1%
Triton X-100 for 10 min at room temperature, and then incubated in 50 mM
glycine in PBS to saturate reactive groups generated by formaldehyde fix-
ation. Nonspecific binding was blocked by incubation in PBS containing
2% donkey serum (DS) (Jackson ImmunoResearch Laboratories, Inc.)
and 1% BSA (Sigma Chemical Co.) for 1 h at room temperature. After
extensive washes in PBS-DS (0.2% donkey serum, 0.1% BSA, 5 mM gly-
cine), sections were incubated for 1 h at room temperature with a mixture
of primary antibodies (5 
 
m
 
g/ml), or a mixture of normal mouse and rabbit
IgGs as a control, followed by washing in PBS-DS, and incubation for 1 h
at room temperature with a cocktail of F(ab
 
9
 
)
 
2
 
 secondary antibodies
(Jackson ImmunoResearch Laboratories, Inc.): FITC-conjugated affinity-
purified donkey anti–rabbit IgGs (5 
 
m
 
g/ml) (preadsorbed on bovine,
chicken, goat, guinea pig, hamster, horse, human, mouse, rat, and sheep
serum proteins); indodicarbocyanine (Cy5)-conjugated affinity-purified
donkey anti–mouse IgGs (5 
 
m
 
g/ml) (preadsorbed on serum proteins from
species above). After washing in PBS-DS, sections were mounted in slow-
fade medium (Molecular Probes), and viewed on a Zeiss Axiovert 35M
microscope equipped with a laser scanning confocal attachment (MRC-
1024; Bio-Rad Laboratories), using a 40
 
3
 
 1.3 NA objective lens. Fluores-
cent images were collected by using the 488 (for FITC) and 647 nm (for
Cy5) excitation lines from an argon/krypton mixed gas laser. Color com-
posite images were generated using Adobe Photoshop 4.0 by attributing
the green and red color to either FITC- or Cy5-specific fluorophore spec-
tra depending on experimental conditions. Images were printed with a
Fujix Pictrography 3000 color printer. Each experimental condition was
performed in triplicate. A number of 27 slides from human breast carci-
noma and 11 slides for colon carcinoma were immunostained, with at least
20 microscopic fields scored per slide.
 
Determination of Protein Concentration
 
Protein concentration was determined by dye methods with a Bio-Rad
Laboratories assay kit with BSA as the standard.
 
Reagents
 
mAbs against TIMP-2 (D52) (Shofuda et al., 1998), human MMP2 (2-22)
(Kawano et al., 1997), human Ln-5 
 
g
 
2 chain (D4B5) (Mizushima et al.,
1998), and rat Ln-5 (MIG-1 and TR-1) (Plopper et al., 1996), and poly-
clonal antibody against rat Ln-5 
 
g
 
2 chain (1963) were generated in our
laboratories. Transwells were purchased from Corning-Costar; polyclonal
antibody against human MT1-MMP (AB815) were purchased from
Chemicon International, Inc.; protein A–Sepharose 4B was purchased
from Pharmacia Biotech Sverige.
 
Results
 
We previously showed that, in breast epithelial cells, mi-
gration over Ln-5 is triggered by MMP2 (Giannelli et al.,
1997). In that system, though, MMP2 must be activated
and added exogenously, raising the question as to how
general the mechanism might be, particularly in cell types
that display constitutive migration over Ln-5. To address
this question, we tested the effects of BB94, a hydroxa-
mate compound known to broadly inhibit MMPs, in mi-
gration assays with a panel of epithelial cells that constitu-
tively migrate on Ln-5 (Miyazaki et al., 1993b). In every
case, migration on Ln-5–coated Transwell filters was in-
hibited by BB94 in a dose-dependent manner (Fig. 1).
Similar levels of inhibition were achieved with TIMP-1
and TIMP-2, specific inhibitors of MMPs that are naturally
occurring in tissues (Fig. 2 A). These data were a first indi-
cation that MMPs may be involved in the mechanism that
elicits the constitutive migration of those cells on Ln-5.
In both migration (not shown) and scattering (Fig. 2 B)
assays, the inhibitory activity of BB94 was abolished if Ln-5
had been cleaved with MMP2 before exposure to cells.
Furthermore, the anti–Ln-5 antibody, MIG-1, inhibited
scattering (Fig. 3 A) and blocked migration (Fig. 3 B) on
Ln-5. These results further supported the possibility that
constitutive migration on Ln-5 (i.e., without exogenous ad-
dition of activated MMPs) depends on cleaving Ln-5 with
endogenously produced and activated MMPs.
To investigate this possibility further, we monitored
MMP production by zymography in these cell lines. In Fig.
4, we show representative results with the cell line BRL,
compared with HT1080 cells, known to secrete and acti-
vate pro-MMP2 (Shofuda et al., 1998; Stanton et al., 1998),
and MCF-10A, a breast cell line that instead requires ex-
ogenously activated MMP2 to cleave and migrate on Ln-5
(Giannelli et al., 1997). Gelatin zymography of condi- 
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tioned medium demonstrated that all three cell lines se-
crete a 72-kD gelatinolytic activity corresponding to pro-
MMP2 (Fig. 4 A). However, the 62-kD–activated MMP2
could be detected only in HT1080, not in BRL or MCF-
10A conditioned media (Fig. 4 A). Since MMP2 activation
occurs at the cell surface, we next prepared plasma mem-
branes from these cells and tested them by zymography.
Two gelatinolytic bands at 72 and 62 kD, corresponding to
the latent and activated form of MMP2, respectively, were
detected in plasma membrane preparations from BRL and
HT1080, but not MCF-10A cells (Fig. 4 B).
Cell surface activation of MMP2 may occur via a com-
plex of pro-MMP2 with the tissue MMP inhibitor, TIMP-2,
and the membrane-bound metalloprotease, MT1-MMP, as
described previously (Strongin et al., 1995; Stanton et al.,
1998). To confirm that BRL cells activate MMP2 via this
mechanism, we tested for the presence of plasma mem-
brane–associated TIMP-2 and MT1-MMP. By Western
blotting, TIMP-2 was detectable in the conditioned media
of all three cells. In contrast, only plasma membrane prep-
arations from BRL and HT1080 cells, not MCF-10A cells
(Fig. 4 C) contained TIMP-2. Similarly, membrane-asso-
ciated MT1-MMP was clearly detectable in BRL and
HT1080, and was very faint in MCF-10A cells (Fig. 4 D).
(Note that, in addition, a 43-kD self-processed form of
MT1-MMP [Stanton et al., 1998] was detected in the mem-
brane of HT-1080 cells, [Fig. 4 D, asterisk].) These results
suggested that constitutive migration on Ln-5 may depend
upon secretion of MMP2 and expression of MT1-MMP
and TIMP-2, which are required to activate MMP2.
Surprisingly, however, MMP profiling of the cell line
panel from Fig. 1 showed that three of these cell lines do
not secrete MMP2 (Table I), even though they constitu-
tively migrate on Ln-5. Every migratory cell, however, was
Figure 1. Effects of the hydroxamate MMP inhibitor BB94 on
constitutive cell migration over Ln-5. Indicated cell lines were in-
cubated under optimized conditions (see Materials and Methods
for experimental details) in the upper compartment of Transwell
chambers, which contained purified Ln-5 (200 or 400 ng/ml) in
the lower compartment. Constitutive migration occurred in all
cases. Likewise, BB94 blocked migration in a dose-dependent
fashion. Each bar represents the mean + SD of three wells. The
same results were obtained by coating the lower surface of Trans-
well filters with Ln-5, rather than adding soluble Ln-5 to the
lower chamber.
Figure 2. (A) Effect of TIMPs on BRL migration over Ln-5.
BRL cells were incubated in Transwell chambers, in control me-
dium or in the presence of Ln-5 (200 ng/ml) and the indicated
concentrations of MMP inhibitors in the lower chamber. In the
presence of Ln-5, BRL cells migrate constitutively. Both TIMP-1
and TIMP-2 inhibit migration, to levels comparable to BB94.
Each bar represents the mean 1 SD for cell migration of two
wells. (B) Lack of inhibition by BB94 of scattering induced by
MMP2-cleaved Ln-5. BRL cells were incubated in 24-well culture
plates in control medium (top), Ln-5 (80 ng/ml) (middle) or
MMP2-cleaved Ln-5 (80 ng/ml) (bottom), in the presence of
BB94, 500 nM or 2 mM. Cell morphology was examined under a
phase-contrast microscope after incubation for 16 h. Scattering
occurs with both intact Ln-5 and cleaved Ln-5. However, BB94
inhibits scattering induced by Ln-5, not by cleaved Ln-5, further
supporting involvement of MMPs in the constitutive scattering of
BRL cells. 
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positive for MT1-MMP, suggesting that this cell surface
MMP may be directly involved in cleaving Ln-5 and pro-
moting migration. Therefore, purified Ln-5 was incubated
with recombinant, soluble MT1-MMP. This recombinant
MT1-MMP preparation, produced in a bacterial expres-
sion system, was functional since it activated pro-MMP2 to
the intermediate MMP2 form in vitro, as expected, and
displayed proteolytic activity by gelatin zymography (data
not shown). As shown in Fig. 5 A, recombinant MT1-
MMP cleaved the 
 
g
 
2 subunit of Ln-5 in a dose-dependent
manner. The cleavage products have the same molecular
size of 
 
g
 
2
 
9
 
 (Marinkovich et al., 1992) and 
 
g
 
2x (Giannelli et al.,
1997), respectively, two previously described proteolyti-
cally processed forms of the 
 
g
 
2 subunit (Fig. 5, B and C).
No changes where observed in the size of the other two
subunits of Ln-5, 
 
a
 
3, and 
 
b
 
3 (not shown). A detailed ac-
count of Ln-5 cleavage by MT1-MMP will be published
elsewhere.
Taken together, these results suggested a model whereby
constitutive migration on Ln-5 may be achieved in two
manners: (1) by MMP2 secretion in conjunction with ex-
pression of MT1-MMP, which activates pro-MMP2 and
leads to Ln-5 cleavage (Fig. 6 A); and (2) by expression of
MT1-MMP alone, with no MMP2 secretion, since MT1-
MMP can directly cleave Ln-5 and presumably cause mi-
Figure 3. Inhibitory effects of mAb MIG-1 on Ln-5 BRL cell
scattering and migration. (A) BRL cells were incubated in con-
trol medium (None) or Ln-5 (60 ng/ml) in the presence of mAbs
to Ln5 TR-1 (control) or MIG-1 (20 mg/ml), which blocks migra-
tion induced by MMP2-cleaved Ln-5. Cell morphology was ex-
amined under a phase-contrast microscope after incubation for
16 h. MIG-1, not TR-1, inhibits scattering induced by Ln-5. (B)
Transwell chamber migration of BRL cells, stimulated by Ln-5
(200 ng/ml), is blocked by MIG-1, not TR-1 control, in a dose-
dependent fashion. Each bar represents the mean 1 SD of three
wells.
Figure 4. (A and B) Gelatin zymography of (A) conditioned me-
dia (CM) (60 ml/lane) or (B) crude plasma membrane fractions
(2 mg/lane) from BRL, MCF-10A, and HT-1080 cells. The posi-
tions of pro-MMP9 (92 kD), pro-MMP2 (72 kD), and activated
MMP2 (62 kD) are indicated. Note the presence of activated
MMP2 in BRL, but not MCF-10A plasma membrane fractions.
(C and D) Western blotting of BRL, MCF-10A, or HT-1080 con-
ditioned media (CM) (300 ml/each lane) or crude plasma mem-
brane fractions (2 mg/each lane) with antibodies to TIMP-2 (C)
or MT1-MMP (D). In C, purified human TIMP-2 (50 ng) was run
in the indicated lane. The respective positions of TIMP-2 and
MT1-MMP are indicated to the right of gels. (asterisk) Processed
form of MT1-MMP (see text).
 
Table I. Expression of MMPs and TIMP-2 in Plasma 
Membrane of Normal and Cancer Cells
 
BRL MCF-10A
MDA-
MB-231 HLE HLF DLD-1 HT-29 HT-1080
 
MT1-MMP
 
11 6 11 11 1 1 1 111
 
Pro-MMP2
 
11 2 2 1 1 2 2 1
 
Active MMP2
 
1 2 2 6 6 2 2 111
 
TIMP-2
 
12
 
NT
 
11
 
NT NT
 
11 
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gration (Fig. 6 B). To test this model, we diminished the
expression of MT1-MMP in BRL and HT-29 cells by treat-
ment with rat or human MT1-MMP antisense oligonucle-
otides, respectively.
In cells treated with MT1-MMP antisense, but not with
control, scrambled oligonucleotides, expression of surface
MT1-MMP was reduced by 
 
z
 
67% in HT-29 cells and 40%
in BRL cells (compared with 
 
b
 
-actin internal controls), as
determined by Western blotting followed by scanning den-
sitometry on a Molecular Dynamics FluorImager (not
shown). Importantly, in the antisense-treated cells, there
was 
 
.
 
50% inhibition of constitutive Ln-5 migration (Fig. 7
A), as well as scattering (not shown).
As expected, inhibition was observed both in the MT1-
MMP
 
1
 
, MMP2
 
1
 
, and in the MT1-MMP
 
1
 
, MMP2
 
2
 
 cell
lines. Furthermore, addition of MMP2-cleaved, rather
than intact Ln-5, to antisense-treated cells circumvented
the inhibition of constitutive Ln-5 migration (not shown)
or scattering (Fig. 7 B), supporting a direct relationship
between MT1-MMP expression and Ln-5 cleavage.
In a further test, we used the MMP2 hemopexin-like do-
main (HLD), which inhibits activation of pro-MMP2 by
competitively binding to TIMP-2 and preventing forma-
tion of the activating complex with MT1-MMP (Strongin
et al., 1995). However, HLD is not known to interfere with
MT1-MMP enzymatic activity. HLD significantly inhib-
ited Ln-5 migration of BRL cells (Fig. 8). In contrast, no
inhibition was observed for HT-29 cell migration on Ln-5
(Fig. 8). These results are in agreement with our working
model (Fig. 6) that constitutive Ln-5 migration depends on
both MT1-MMP and MMP2 in BRL cells, whereas, in HT-
29, cells are dependent on MT1-MMP only.
To evaluate the possible relevance of these mechanisms
in vivo, we immunostained with antibodies to Ln-5, MT1-
MMP, and MMP2 sections of human breast (not shown)
or colon cancer tissues (Fig. 9). Double immunofluores-
cence and confocal microscopy indicated that Ln-5, which
was expressed predominantly at the outer edge of cancer
cell nests, colocalized with either MT1-MMP or MMP2 at
many locations (Fig. 9, arrows). These results are consis-
tent with the possibility that Ln-5 cleavage, and conse-
quent induction of migration, occurs at defined locations
corresponding to areas of the cell surface where either
MT1-MMP or activated MMP2 are expressed.
 
Discussion
 
We report that Ln-5 cleavage by MMPs may be a wide-
spread mechanism that triggers cell migration. This con-
clusion is based on the following findings: (1) in several
cell lines that migrate (or scatter) constitutively on Ln-5,
migration (or scattering) on Ln-5 was blocked by inhibi-
tors of MMPs, both naturally occurring, like TIMPs, or
synthetic, like BB94; (2) in these cell lines, the ability to
Figure 5. Cleavage of Ln-5 by MT1-MMP. (A)
Ln-5 (1 mg) was treated with recombinant solu-
ble MT1-MMP at the indicated concentrations,
electrophoresed by 6% SDS-PAGE under re-
ducing conditions, and then analyzed by Western
blotting with a polyclonal antibody (1963)
against rat Ln-5 g2 chain. The positions of Ln-5
g2 (140 kD), g29 (100 kD), and g2x (80 kD)
chains are indicated. In the presence of increas-
ing concentrations of MT1-MMP, the g2 appears
to chase into the g29 and the g2x chain. (B) Sche-
matic depiction of the position of the MMP2
cleavage site (Giannelli et al., 1997) and the pre-
dicted position of the MT1-MMP sites. The g29
has been described (Vailly et al., 1994). (C)
Scheme of the predicted size of MMP2 and MT1-
MMP cleavage products of the Ln-5 g2 chain.
Figure 6. Schematic model for mechanisms of MMP-dependent
Ln-5 cell migration. 
Koshikawa et al. 
 
Role of MP 1-MMP in Epithelial Cell over Ln-5
 
621
 
migrate constitutively on Ln-5 correlated with expression
of membrane bound MT1-MMP; (3) decreasing expres-
sion of MT1-MMP via antisense oligonucleotides inhibited
migration; and (4) purified Ln-5 itself was cleaved in vitro
by MT1-MMP with a pattern similar to MMP2, thus, pro-
viding a mechanism for induction of migration (Giannelli
et al., 1997).
These findings significantly extend the physiological im-
plications of our previous report that cleavage of Ln-5 by
MMP2 may induce migration (Giannelli et al., 1997). In
that report, we had shown that adding exogenously acti-
vated MMP2 to purified Ln-5 changed the latter into a
substrate that triggered cell migration. The only indication
that the mechanism may operate in vivo was that Ln-5
fragments, similar to those generated by MMP2, were de-
tectable in remodeling, but not in quiescent tissues. Here
we show that, in fact, cells that have the constitutive ability
to migrate on Ln-5 do so by using an MMP-dependent
mechanism. MMP2 was secreted and activated by several
of the constitutive migratory cells. This MMP also contrib-
uted to stimulating migration, since its HLD fragment,
which blocks its activation, inhibited migration. However,
inhibition was only partial in MT1-MMP
 
1
 
, MMP21 cells,
and nondetectable in MT1-MMP1, MMP22 cells. To-
gether, these results suggest a model whereby one pre-
ferred mode for stimulating migration on Ln-5 is via MMP
cleavage of Ln-5 itself. Cleavage may be carried out by
MT1-MMP alone or in concert with MMP2. Since MT1-
MMP is required to activate MMP2, it is likely that
MT1-MMP plays an essential role in this mechanism,
whereas MMP2 may represent a potentiation loop. An at-
tractive feature of this model is that, whether Ln-5 is
cleaved by MT1-MMP alone or by MT1-MMP–activated
MMP2, the proteolytic components are anchored onto the
cell surface because MT1-MMP is a transmembrane pro-
tein. Thus, spatially directed cleavage of Ln-5 may occur,
perhaps coincident with hot spots for migration.
By incubating recombinant MT1-MMP with purified
Ln-5, we showed, for the first time, that Ln-5 is a pro-
teolytic substrate for MT1-MMP (Fig. 5). While the details
of this cleavage are being currently characterized and will
be published elsewhere, it is clear that only the g2 subunit
of Ln-5 is cleaved by MT1-MMP, whereas the a3 and b3
subunits remain intact. The Ln-5 g2 subunit is synthesized
as a 135-kD polypeptide which is proteolytically processed
(Vailly et al., 1994) by removal of 434 NH2-terminal amino
acids (g29). The enzyme that carries out this processing is
not known, but our preliminary results indicated that it
may be MT1-MMP. This would be consistent with the pat-
tern generated by digestion of purified Ln-5, showing a
time-dependent increase in g29 (Fig. 5). MMP2 can cleave
both g2 and g29, yielding an 80-kD g2x chain (Giannelli et
al., 1997). It is clear that MT1-MMP can also produce the
g2x fragment (Fig. 5). Thus, we predict two MT1-MMP
cleavage sites on Ln-5 (Fig. 5, B and C).
Figure 7. Effect of MT1-MMP antisense oligonucleotides on Ln-5
migration by BRL or HT-29 cells. (A) Cells were pretreated for
2 d in culture with MT1-MMP antisense (AS) or control, scram-
bled (Cont.) oligonucleotides, and tested in migration assays. Ln-5
and oligonucleotides, at the same concentrations as treatment, or
PBS were present throughout the assay in the lower Transwell
chambers. Each bar represents the mean 1 SD for cell migration
of two (BRL) or four (HT-29) wells. (B) BRL cells were pre-
treated with MT1-MMP AS or control oligonucleotides, and
tested in the scattering assay as in Fig. 2, in the presence of either
intact or MMP2-cleaved Ln-5. Addition of either intact or
MMP2-cleaved Ln-5 causes a morphological change in BRL
cells, which loosen cell–cell contacts, elongate, and scatter. MT1-
MMP AS treatment inhibits these morphological changes when
they are induced by intact Ln-5. In contrast, cleaved Ln-5 still
causes scattering of AS-treated cells, supporting a link between
reduction of MT1-MMP expression, Ln-5 cleavage and scattering
response.
Figure 8. Effect of MMP2 HLD on Ln-5 migration by BRL or
HT-29 cell. Purified HLD was added to the lower Transwell
chambers at 0, 1, or 3 mg/ml. Results shown are from two sepa-
rate, representative experiments (1 and 2) performed on differ-
ent occasions. Each bar represents the mean 1 SD for cell migra-
tion of four wells.The Journal of Cell Biology, Volume 148, 2000 622
Miyazaki and colleagues described ladsin, a soluble pro-
tein in the spent media of several epithelial cell lines, that
induced scattering and migration within hours upon addi-
tion to cultured cells (Miyazaki et al., 1993b). Ladsin
turned out to be identical to Ln-5 (Mizushima et al., 1996),
raising the following apparent conflict: in epithelial tissues
and in certain culture systems, Ln-5 promotes static adhe-
sion of epithelial cells via formation of hemidesmosomes;
in contrast, ladsin promotes an opposite effect, scattering.
Our results provide an explanation for this apparent con-
flict and reconcile the data in the literature. Thus, MT1-
MMP1 cell lines are capable of cleaving Ln-5 into its mi-
gratory form, directly and via activation of MMP2, if
present. In contrast, MT1-MMP2 cells leave Ln-5 intact
and use it for static adhesion.
To date, MT1-MMP was only known to digest collagens
I, II, and III. Our results add new perspective in at least
two respects. First, the substrate Ln-5 is located in the BM,
in direct contact with epithelial cells, which are anchored
to it via receptor integrins (a3b1 or a6b4). In contrast, ep-
ithelial cells do not express receptors for collagen IV (inte-
grin a1b1) and, as far as we are aware, there is no report of
MT1-MMP cleaving collagen IV or of promigratory activ-
ity by collagen fragments. Thus, it is possible that, in the
context of the BM, the Ln-5 substrate may play a promi-
nent role in mediating MT1-MMP effects on epithelial
cells. Second, because the Ln-5 cleavage mechanism may
work in tissue remodeling and repair (Giannelli et al.,
1997, 1999), it is expected to be spatially constrained. This
requirement may be fulfilled by MT1-MMP, which is
transmembrane-anchored and presumably does not dif-
fuse freely in the extracellular space, so that it may be tar-
geted at discrete BM sites by cell surface contact. In ad-
dition, MT1-MMP may also constrain spatially MMP2,
which is secreted extracellularly, by recruitment via TIMP-2
(see below).
All evidence indicates that upon addition to constitutive
migratory cell types, Ln-5 is cleaved by MMPs. However,
in spite of extensive efforts, we were not able to detect
cleaved Ln-5 in these cultures. This is not entirely surpris-
ing, in view of the fact that relatively small amounts of
Ln-5 molecules may gain access to relevant cell surface
sites, and nonetheless exert their biological effect when
MMP cleaved. More sensitive detection methods may
shed light on this point. Previously, it was reported that
cleavage of the Ln-5 a3 chain by plasmin correlated with
nucleation of hemidesmosomes (Goldfinger et al., 1998),
presumably inhibiting cell migration. Therefore, it is possi-
ble that plasmin and metalloproteases act coordinately to
regulate epithelial cell migration on Ln-5.
MMPs are involved in tissue remodeling under various
physiological and pathological conditions such as morpho-
genesis, angiogenesis, inflammation, tissue repair, and tu-
mor invasion (Matrisian, 1992; Stetler-Stevenson et al.,
1993). In particular, inflammatory macrophage and malig-
nant cancer cells secrete MMP2 to degrade BM and con-
nective tissue ECM to invade. Deryugina et al. (1997)
have shown that MMP2 activation and integrin avb3 mod-
ulate glioma cell migration on ECM. MMP2 also modu-
lates melanoma cell attachment and facilitates migration
and invasion (Ray and Stetler-Stevenson, 1995). Ln-5 also
has been associated with carcinoma cell invasion. In par-
ticular, the g2 chain of Ln-5 was detected at the leading
edge of invasive colon and breast cancer tissue (Pyke et al.,
1995; Sordat et al., 1998). In our study, migration of
hepatoma, breast and colon carcinoma cells was induced
by Ln-5, via the MMP cleavage mechanism. Furthermore,
colocalization of Ln-5 with MT1-MMP and MMP2 was de-
tected in breast and colon cancer tissue. Thus, our results
suggest a mechanistic framework for the observed associa-
tion between MMPs and invasion, or Ln-5 and invasion.
We propose that MT1-MMP cleavage of Ln-5 is a candi-
date to play a role in the early phases of tissue invasion,
e.g., when carcinoma in situ may still be dependent on ex-
ternal factors to initiate local invasion. These issues are de-
serving of further investigation because of their obvious
relevance to cancer progression.
Our results raise several questions concerning the regu-
Figure 9. Detection of Ln-5, MT1-MMP, and
MMP2 in human colon carcinoma tissue speci-
mens by double immunofluorescence and confo-
cal microscopy. Cryostat sections were double
immunostained for either Ln-5 and MT1-MMP
or Ln-5 and MMP2. Expression of Ln-5 is dis-
crete, in some cases limited to the outside layer
of cell nests. Colocalization with MT1-MMP and
MMP2 is shown in the panels on the right (yel-
low) by combining the specific fluorophore spec-
tra recorded for Ln-5 (green) and MT1-MMP or
MMP2 (red). Examples of colocalization are in-
dicated by arrowheads. A slight difference in
the appearance of Ln-5–specific immunoreac-
tivity in top and middle panels is due to the use of
either mouse mAb D4B5 (combination with rab-
bit anti–MT1-MMP) or rabbit polyclonal 1963
(combination with mouse monoclonal to MMP2).
Control sections incubated with normal mouse
IgGs and rabbit IgGs were completely negative
(not shown). Bar size, 43 mm.Koshikawa et al. Role of MP 1-MMP in Epithelial Cell over Ln-5 623
lation of motility of epithelial cells in contact with Ln-5. In
particular, it is important to determine how MMPs may be
deployed. An attractive possibility is that epithelial cells
may be stimulated to synthesize MT1-MMP by environ-
mental signals and factors in situations that require re-
modeling, e.g., steroid-induced branching morphogenesis
(Yu et al., 1997; Kadono et al., 1998). Alternatively, MMPs
may be delivered to remodeling sites by third party cells,
stromal or inflammatory. These mechanisms may also be
exploited, inappropriately, by invading carcinoma cells.
Another important issue concerns the nature of the cellu-
lar interactions with cleaved Ln-5, which trigger migration.
Integrins are likely to play an important role because they
can mediate adhesion and migration. Additional studies
are now necessary to further our understanding of these
molecular mechanisms of invasion, both in normal and
neoplastic tissues.
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